drugset / Trial / NCT04398719
CBD-Microglia PET Study
Phase 0
Completed
28 enrolled
Yale University
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupTriple-blindOther
Summary
This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.
Timeline
- Start
- 2021-05-07
- Primary completion
- 2024-12-11
- Completion
- 2024-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Intradermal Capsaicin | Unknown | — | Intramuscular |
| Comparator | Low-dose lipopolysaccharide | Unknown | — | Intravenous |
Indications
No indication recorded.